Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/23/2015 07/24/2015 07/27/2015 07/28/2015 07/29/2015 Date
556.61(c) 541.85(c) 540.03(c) 552.45(c) 546.27(c) Last
492 476 933 390 658 253 872 005 648 472 Volume
+0.01% -2.65% -0.34% +2.30% -1.12% Change
More quotes
Financials ($)
Sales 2015 3 735 M
EBIT 2015 1 415 M
Net income 2015 487 M
Finance 2015 1 443 M
Yield 2015 -
Sales 2016 4 511 M
EBIT 2016 1 940 M
Net income 2016 888 M
Finance 2016 2 935 M
Yield 2016 -
PER 2015 132,55
PER 2016 71,99
EV / Sales 2015 14,7x
EV / Sales 2016 11,9x
Capitalization 56 417 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
07:31a REGENERON PHARMACEUTICALS : Assigned Patent
07/29 REGENERON PHARMACEUTICALS : and Sanofi Announce CHMP Recommends European Approva..
07/29 REGENERON PHARMACEUTICALS : Pharma Enters into Co-Development Agreement with San..
07/28DJSANOFI : Regeneron Enter Major New Immuno-Oncology Collaboration
07/24DJFDA Approves Cholesterol Drug From Regeneron, Sanofi -- UPDATE
07/24DJFDA Approves Cholesterol Drug From Regeneron, Sanofi
07/24DJFDA Approves Cholesterol Drug From Regeneron, Sanofi
07/22 REGENERON PHARMACEUTICALS : Patent Issued for Humanized IL-6 and IL-6 Receptor
More news
Sector news : Pharmaceuticals - NEC
08:07aDJAstraZeneca Boosted by Licensing Deals -- 2nd Update
07:45a ASTRAZENECA : Ups Revenue Guidance As First Half Profit Falls (UPDATE)
07:39a ASTRAZENECA : IN THE KNOW: Analysts Positive As AstraZeneca Interims Beats Forec..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06:00a REGENERON'S MEGA-BLOCKBUSTER POTENTI : CVS Health Sees It, So Why Don't More Ana..
07/29 PREMARKET BIOTECH DIGEST : Merck Earnings, Gilead Beats Again, NantKwest Surges
07/28 Sanofi and Regeneron extend collaboration; Sanofi commits $2.2B in immuno-onc..
07/28 PREMARKET BIOTECH DIGEST : PD-1 Inhibitors, Mylan Takeover Canceled, NantKwest I..
07/27 BIOGEN FALLS HARD : Is It Undervalued Now?


Comments 
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends REGENERON PHARMAC...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions